Search results
Results from the WOW.Com Content Network
Infrapatellar bursitis is inflammation of the superficial or deep infrapatellar bursa. [3] Symptoms may include knee pain , swelling, and redness just below the kneecap . [ 2 ] It may be complicated by patellar tendonitis .
Infrapatellar fat pad syndrome, also known as Hoffa's disease, is when pain in the front of the knee occurs due to problems with the infrapatellar fat pad. [2] Pain is generally just below the kneecap. [2] Symptoms may worsen if the knee is overly straightened or bent for too long a period. [2]
the deep infrapatellar bursa between the upper part of the tibia and the patellar ligament. [2] It allows for movement of the patellar ligament over the tibia. [4] the subcutaneous (or superficial) infrapatellar bursa between the patellar ligament and skin. [2] the pretibial bursa between the tibial tuberosity and the skin. [2]
The diagnosis of patellofemoral pain syndrome is made by ruling out patellar tendinitis, prepatellar bursitis, plica syndrome, Sinding-Larsen and Johansson syndrome, and Osgood–Schlatter disease. [23] Currently, there is not a gold standard assessment to diagnose PFPS. [20]
Furthermore, studies have found knee pain to be negatively associated with health-related quality of life, and an increase in knee pain to be associated with a reduction in patient-reported quality of life, as compared to those with no or stable knee pain, even in the relatively younger middle-aged population. [34]
Other conditions that can appear similar include infrapatellar bursitis, chondromalacia patella and patellofemoral syndrome. [1] [2] Treatment often involves resting the knee and physical therapy. [2] Evidence for treatments, including rest, however is poor. [4] [5] Recovery can take months and persist over years.
Here is what we know about polio as a disease, its vaccines and the likely number of lives saved through inoculation.
The package leaflet supplied with the product is aimed at end-users. [3] A cartoon by Roy Doty depicting the package insert as overly long and complicated. In the United States, the Food and Drug Administration (FDA) determines the requirements for patient package inserts.